Cognito Therapeutics

Person standing by a large window with their back turned looking at a large mountain
By  Jessica Hagen 02:34 pm October 31, 2023
FireflyVR, a company that develops virtual reality software for mental healthcare, announced the appointment of Andy Mathis as its new chief business officer and Steve Howarth as its chief financial officer.  Mathis' previous roles include head of Android carrier partnerships in North America at Google, head of customer account management at Oculus, director of healthcare partnerships for the...
Cognito's neuromodulation device
By  Jessica Hagen 09:52 am March 23, 2023
Cognito Therapeutics, a startup using visual and auditory stimulation to treat neurodegenerative disorders, scored $73 million in a Series B funding round led by FoundersX Ventures, bringing its total raise to $93 million. All existing investors participated in the round alongside new investors Starbloom Capital, Alzheimer's Drug Discovery Foundation, WS Investment Company and IAG Capital. In...
A man using an AppliedVR headset at home.
By  Emily Olsen 02:34 pm August 26, 2021
Curebase, a platform for decentralized clinical trials, is partnering with AppliedVR to run five trials to test the effectiveness of virtual reality for treating chronic pain. The companies said the one-year partnership will focus on studying a self-administered, at-home VR therapy program. Curebase will manage patient recruitment, consent, and engagement, and collect patient-reported outcomes...
A nerve cell affected by Alzheimer's disease
By  Dave Muoio 02:25 pm March 10, 2021
Yesterday Cognito Therapeutics, a startup using visual and auditory stimulation to treat neurodegenerative disorders, announced Phase 2 trial results suggesting its gamma frequency neuromodulation therapy slowed declines in memory and cognition among mild-to-moderate Alzheimer's disease patients. The OVERTURE study, a multi-center, randomized controlled trial, enrolled 76 such patients aged 50...